Jubilant DraxImage launches “Not all Iodine-131 is created equal” Campaign

Jubilant DraxImage is pleased to announce the launch of its “Not all Iodine-131 is created equal” campaign. We wish to raise awareness about the differences between FDA approved pharmaceutical-grade I-131 drug products such as Jubilant DraxImage’s HICON® I-131 and radiochemical-grade I-131. Our communication is intended for Nuclear Technologists and Nuclear Medicine Physicians involved in Thyroid patients’ care.

JDI supports the ongoing education of the Nuclear Medicine Community through a number of programs. Today, we are creating the first ever “HICON® Continuing Education Grant” initiative bringing to light the extraordinary value that Nuclear Medicine brings to Thyroid patients. To qualify for a chance to win a $5,000 unrestricted grant towards continuing education, nuclear medicine professionals in the U.S.A. are invited to visit this webpage: http://hiconeducationgrant.com and complete a very short survey.

This initiative is another example of Jubilant DraxImage’s commitment to quality and education in support of nuclear medicine.

Leave a Reply

Share this news!